Nordic Nanovector Presentations at the Annual Congress of the European Association of Nuclear Medicine (EANM)

OSLO, Norway, Oct. 12, 2018 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that the Company and its collaborators will present data and analyses from its non-clinical and clinical studies with Betalutin® (177Lu-lilotomab satetraxetan) at the......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Friday, 12 October

Share |